ResearcherKagoshima UniversityNo recent work listed
Tomomi Hayashi
Matched on ORCID iD 0009-0008-1256-8257; OpenAlex author ID A5108723732. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2011: 1 paper · 2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: 1 paper
Papers 4
- CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. Co-author DOI 10.3390/ijms17071025↗
- Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic c… Co-author DOI 10.1007/s13577-011-0037-9↗
- Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. Co-author DOI 10.1111/j.1349-7006.2012.02235.x↗
- Advanced staging laparoscopy using single-incision approach for unresectable pancreatic cancer. Co-author DOI 10.1097/sle.0b013e31823bae57↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sonshin Takao · 4 shared papers, 2011–2016 · strength 0.14
- Paper CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. DOI 10.3390/ijms17071025↗
- Paper Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. DOI 10.1111/j.1349-7006.2012.02235.x↗
- Paper Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelia… DOI 10.1007/s13577-011-0037-9↗
- Shoji Natsugoe · 4 shared papers, 2011–2016 · strength 0.14
- Paper CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. DOI 10.3390/ijms17071025↗
- Paper Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. DOI 10.1111/j.1349-7006.2012.02235.x↗
- Paper Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelia… DOI 10.1007/s13577-011-0037-9↗
- Yumi Miyazaki · 3 shared papers, 2012–2016 · strength 0.12
- Paper CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. DOI 10.3390/ijms17071025↗
- Paper Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. DOI 10.1111/j.1349-7006.2012.02235.x↗
- Paper Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelia… DOI 10.1007/s13577-011-0037-9↗
- Koki Maeda · 3 shared papers, 2012–2016 · strength 0.12
- Paper CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. DOI 10.3390/ijms17071025↗
- Paper Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. DOI 10.1111/j.1349-7006.2012.02235.x↗
- Paper Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelia… DOI 10.1007/s13577-011-0037-9↗
- Qiang Ding · 3 shared papers, 2012–2016 · strength 0.12
- Paper CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. DOI 10.3390/ijms17071025↗
- Paper Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. DOI 10.1111/j.1349-7006.2012.02235.x↗
- Paper Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelia… DOI 10.1007/s13577-011-0037-9↗
- Koichiro Tsukasa · 1 shared paper, 2016 · strength 0.06
- Hiroyuki Shinchi · 1 shared paper, 2016 · strength 0.06
- Shyuichiro Matsubara · 1 shared paper, 2012 · strength 0.03
- Kosei Maemura · 1 shared paper, 2011 · strength 0.03
- Hiroshi Kurahara · 1 shared paper, 2011 · strength 0.03
- Yuko Mataki · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.